Published: August 09, 2021 DOI: https://doi.org/10.1016/j.jinf.2021.08.010
A new science paper published in the Journal of Infection appears to provide solid evidence that the vaccines being administered around the world will, without question, cause ADE effects in people when they are exposed to the Delta variant or potentially other coronavirus strains. The study is entitled, Infection-enhancing anti-SARS-CoV-2 antibodies recognize both the original Wuhan/D614G strain and Delta variants. A potential risk for mass vaccination?
What is ADE?
ADE occurs when the antibodies generated during an immune response (from vaccine in this case) recognize and bind to a pathogen, but they are unable to prevent infection. Instead, these antibodies act as a “Trojan horse,” allowing the pathogen to get into cells and exacerbate the immune response.
Written from the point of view of conventional virology and epidemiology, it explains that while the current vaccines (based on the original Wuhan D615G strain) do provide some level of immunity against the original covid virus, they present an unfortunate side effect: The acceleration of “infection-enhancing antibodies” which overreact to Delta variant infections. What the paper is describing is classic ADE, meaning a hyperinflammatory reaction can kill the person as their “primed” immune system overreacts to new infections. In other words, it is the second infection, the flu or cold a year after vaccination that can kill the patient.
The study concludes, “ADE of delta variants is a potential risk for current vaccines,” and it goes on to explain the mechanism by which this ADE is emerging. The study suggests that the original vaccines should be essentially scrapped, and replaced with new, “second generation” vaccines that are engineered to attack the antigen targets of the Delta variant.